Male pill, delayed gratification and... er... asthma attacks
A round-up of the health news headlines on Friday 17 August
The elusive male contraceptive pill is closer to reality, according to a study published in US journal Cell.
The study found a new drug could make mice temporarily infertile without hampering their sex drive, the BBC reports.
The drug, JQ1US, was tested by researchers at the Dana-Farber Cancer Institute and Baylor College. It targets a protein that exists only in the testes and is critical for sperm production.
Staying on parenting (or the lack of), another study today shows that children who resist sweets are less likely to be obese as adults.
In tests between 1968 and 1974, 653 four-year-olds were given sweet treats and told they would be given more later if they resisted eating it, the Telegraph reports.
The results, published in the Journal of Pediatrics, showed that each minute a child delayed gratification predicted a 0.2 point decrease in adult BMI, calculated by dividing weight by height squared.
Staying with the Telegraph, it reports that a new treatment for asthma could cut hospital admissions by half.
The research, conducted by a team at Leicester University and published in The Lancet, found mepolizumab could reduce severe asthma attacks, A&E visits and admissions to hospital by 50% compared with placebo.